EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer.

Laura BiganzoliSaverio CinieriRossana BerardiRebecca PedersiniAmelia McCartneyAlessandro Marco MinisiniElena Rota CaremoliSimon SpazzapanEmanuela MagnolfiAntonella BrunelloEmanuela RisiRaffaella PalumboSilvana LeoMarco ColleoniSara DonatiSabino De PlacidoLaura OrlandoMirco PistelliVeronica ParolinAnna MislangDimitri BecheriFabio PuglisiGiuseppina SannaElena ZafaranaLuca BoniGiuseppe Mottino

Published in: Breast cancer research : BCR (2020)

EudraCT, 2012-002707-18 . Registered on June 4, 2012. NIH ClinicalTrials.gov, NCT02783222 . Retrospectively registered on May 26, 2016.

Keyphrases

phase ii study
open label
locally advanced
advanced non small cell lung cancer
community dwelling
middle aged
placebo controlled
radiation therapy
clinical trial
double blind
childhood cancer